Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 14.0 Good

AI and computer simulation open new paths in drug discovery – Masahito Ohue

AI and simulation are accelerating drug discovery, a beneficial medical application with no immediate risk.

AI and simulation are accelerating drug discovery, a beneficial medical application with no immediate risk.

Auto-scored: Substantive scientific progress in AI-driven drug discovery, a verified beneficial development.